Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

General

Leading Pro-Life Research Group Welcomes New Executive Director

FOR IMMEDIATE RELEASE: March 12, 2024

Contact: [email protected]  

Washington D.C.—The Charlotte Lozier Institute, the nation’s premier research and education institute on pro-life issues, welcomes its new executive director, Karen M. Czarnecki, a seasoned non-profit and government leader.  

“Karen has deep roots and experience that span policy and academic worlds and all sectors of federal government for three decades,” said Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America. “She has stepped up to lead and navigate those worlds at a critical, turning point for science in support of women and children.” 

“At this pivotal time in our nation, I am humbled to join the dedicated staff of the Charlotte Lozier Institute in promoting educational research in the defense of life,” said Czarnecki. “Providing scientific, fact-based, reliable research on life issues for policymakers and opinion leaders is critical if we wish to promote a culture of life and advance policies that are life-affirming for women and their children.” 

Czarnecki’s extensive public policy career includes her most recent role as vice president of outreach for the Mercatus Center at George Mason University, where she was responsible for all government relations and external affairs activity for the organization’s priority research issues. She also served as the director of education at the Law & Economics Center (LEC) at George Mason University’s Antonin Scalia Law School where she oversaw executive education for federal and state court judges, state attorneys general and their staffs, as well as a congressional staff education program on legal reform. 

In over two decades in the public policy field, Czarnecki has served as a congressional chief of staff and a senior-level outreach and communications adviser. Her roles in the federal government have included serving as acting assistant secretary and deputy assistant secretary for a Cabinet-level agency. Earlier in her career, she served in policy roles in the White House for two administrations.  

For over a decade, she has taught a public policy seminar as an adjunct professor at George Mason University for The Fund for American Studies. Czarnecki earned her BA and JD from The Catholic University of America. 

 

Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony Pro-Life America. CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The Institute is named for a feminist physician known for her commitment to the sanctity of human life and equal career and educational opportunities for women.  

  

### 

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Graphic featuring a series of black horizontal brushstrokes leading into a circular geometric pattern, followed by the letters FDA in a stylized font, set against a white crinkled paper background for a peer-reviewed article on the abortion drug.

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026

Abortion Reporting: Ohio (2025)

A stylized white geometric design resembling a circular burst is centered over a dark blue map outline of the United States, highlighting the complexities of U.S. law and FDA safety limits around online abortion drug sellers.

New CLI Report: Online Abortion Drug Sellers Violating U.S. Law and FDA Safety Limits

charlotte-lozier-institute Charlotte Lozier Institute
May 26, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image